Method for preparing high-purity pomalidomide
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- TIANJIN WEIJIE TECH
- Publication Date
- 2014-05-21
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of medicine, in particular to a preparation method of high-purity pomalidomide. Background technique
[0002] Pomalidomide is a derivative of Thalidomide. It has the same stability as Thalidomide. It is the most active immunomodulatory drug so far, which can regulate T cells and inhibit their proliferation. , by activating natural killer cells, promoting the apoptosis of tumor cells, and exerting an immunoregulatory effect, it is mainly used clinically for the treatment of multiple myeloma. Multiple myeloma, a type of blood cancer that starts in plasma cells in the bone marrow, mainly affects the elderly. According to the National Cancer Institute, approximately 21,700 Americans are diagnosed with multiple myeloma each year and 10,710 die from the disease. The US Food and Drug Administration (FDA) approved Pomalyst (pomalidomide) on February 8, 2013 for the treatment of multiple myeloma patients whose dise...